Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: Safe and effective

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 4, 2007, Pages 469-473

  Van Den Akker, E S A ^a   Oepkes, D ^a   Lopriore, E ^a   Brand, A ^a   Kanhai, H H H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alloimmune thrombocytopenia; Fetal blood sampling; HPA 1a; Intracranial haemorrhage; Intravenous immunoglobulins; Noninvasive treatment

Indexed keywords

IMMUNOGLOBULIN;

ALLOIMMUNIZATION; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; CESAREAN SECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FETUS; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DEATH; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ANTIBODIES; ANTIGENS, HUMAN PLATELET; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; PLATELET TRANSFUSION; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 33847775315     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01244.x     Document Type: Article

References (20)

1. Blanchette VS, Chen L, de Friedberg ZS, Hogan VA, Trudel E, Decary F. Alloimmunization to the PlA1 platelet antigen: results of a prospective study. Br J Haematol 1990;74:209-15.
2. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G, et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Blood 1997;89:4402-6.
3. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Br J Haematol 1998;92:2280-7.
4. Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363-6.
5. Bussel JB, Berkowitz RL, Lynch L, Lesser ML, Paidas MJ, Huang CL, et al. Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. Am J Obstet Gynecol 1996;174:1414-23.
6. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45-5.
7. Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988;319:1374-8.
8. Berkowitz RL, Bussel JB, McFarland JG. Alloimmune thrombocytopenia: state of the art 2006. Am J Obstet Gynecol 2006;195:907-13.
9. Radder CM, Brand A, Kanhai HHH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 2001;185:683-8.
10. Kanhai HHH, van den Akker ESA, Walther FJ, Brand A. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage. Fetal Diagn Ther 2006;21:55-60.
11. Birchall JE, Murphy MF, Kaplan C, Kroll H. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 2003;122:275-88.
12. Berkowitz RL, Kolb EA, McFarland JG, Wissert M, Primani A, Lesser M, et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 2006;107:91-6.
13. Paidas MJ, Berkowitz RL, Lynch L, Lockwood CJ, Lapinski R, McFarland, et al. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol 1995;172:475-9.
14. Overton TG, Duncan KR, Jolly M, Letsky E, Fisk NM. Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome. Am J Obstet Gynecol 2002;186:826-31.
15. Radder CM, Roelen DL, Van de Meer-Prins EM, Claas FHJ, Kanhai HHH, Brand A. The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 2004;191:815-20.
16. Radder CM, de Haan MJJ, Brand A, Stoelhorst GMSJ, Veen S, Kanhai HHH. Follow up of children after antenatal treatment for alloimmune thrombocytopenia. Early Hum Dev 2004;80:65-76.
17. Nicolini U, Kochenour NK, Greco P, Letsky EA, Johnson RD, Contreras M, et al. Consequences of fetomaternal haemorrhage after intrauterine transfusion. BMJ 1988;297:1379-81.
18. Bertrand C, Martageix C, Jallu V, Vitry F, Kaplan C. Predictive value of sequential anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 2006;4:628-37.
19. van den Akker ESA, Oepkes D, Brand A, Kanhai HHH. Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia? BJOG 2006;113:781-3.
20. Radder CM, Brand A, Kanhai HHH. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sang 2003;84:318-25.